Greenwood A M, Menendez C, Todd J, Greenwood B M
Medical Research Council Laboratories, Fajara, Banjul, The Gambia.
Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):311-2. doi: 10.1016/0035-9203(94)90094-9.
The distribution of birth weights among the infants of 172 Gambian primigravidae who had received chemoprophylaxis with Maloprim (pyrimethamine+dapsone) during pregnancy was compared with that of the infants of 149 primigravidae who had received placebo. Administration of chemoprophylaxis led to a reduction in the prevalence of low birth weight babies and to an increase in the median birth weight. However, these changes were not accompanied by a comparable increase in the prevalence of high birth weight babies. The perinatal mortality rate was lower, although not significantly so, among the babies of women who had received chemoprophylaxis. Thus, no evidence was found to support the view that administration of chemoprophylaxis might increase the risks of delivery by causing cephalo/pelvic disproportion.
将172名在孕期接受过乙胺嘧啶-氨苯砜联合化学预防的冈比亚初产妇所生婴儿的出生体重分布,与149名接受安慰剂的初产妇所生婴儿的出生体重分布进行了比较。进行化学预防导致低体重儿患病率降低,中位数出生体重增加。然而,这些变化并未伴随高体重儿患病率出现相应增加。在接受化学预防的女性所生婴儿中,围产期死亡率较低,尽管差异不显著。因此,未发现证据支持化学预防可能通过导致头盆不称而增加分娩风险这一观点。